• Sulfamonomethoxine: Translating Mechanism to Aquatic and Vet

  2026-07-28

  Explore the science behind Sulfamonomethoxine (SMM), a potent veterinary antibiotic for bacterial infections, with a focus on its translational value from molecular mechanism to real-world aquaculture and livestock protocols. This in-depth article uniquely connects environmental, mechanistic, and practical assay insights.

• Deep Learning Uncovers Cardiotoxicity via iPSC-CM Screening

  2026-07-28

  Grafton et al. introduced a scalable deep learning pipeline for high-content detection of cardiotoxicity using iPSC-derived cardiomyocytes. Their approach enables early identification of compounds with cardiac risk, informing safer drug development and optimizing phenotypic screening workflows.

• Alpha-Ketoglutarate in Immunometabolic Research: From TCA Cy

  2026-07-27

  Explore the pivotal roles of alpha-ketoglutarate in metabolic and immune modulation, with insights from cutting-edge research on tumor microenvironments. This article offers advanced perspectives for metabolic reprogramming research beyond standard protocols.

• Angiotensin 1/2 (2-7): Mechanism, Evidence & Research Utilit

  2026-07-27

  Angiotensin 1/2 (2-7) is a biologically active peptide fragment critical for blood pressure regulation research. It acts as a vasoconstrictor and is pivotal in renin-angiotensin signaling studies. Recent evidence highlights its role in both cardiovascular and viral pathogenesis models.

• HyperScript™ Reverse Transcriptase: Precision for Structured

  2026-07-26

  HyperScript™ Reverse Transcriptase, engineered from M-MLV Reverse Transcriptase, delivers robust cDNA synthesis from challenging RNA templates—even those with complex secondary structures or low abundance. Its advanced thermal stability and reduced RNase H activity empower researchers to push the boundaries of qPCR, transcriptomics, and translational discovery in oncology and beyond.

• Sulfachloropyridazine: Precision Use in Microbial Ecology &

  2026-07-25

  Sulfachloropyridazine empowers researchers with targeted inhibition of bacterial folate synthesis, delivering robust results across antimicrobial susceptibility testing and complex microbiome studies. Advanced workflows and troubleshooting tips unlock its full experimental potential in both routine and novel research settings.

• Latrunculin A: Reversible Inhibitor of Actin Assembly in Cel

  2026-07-24

  Latrunculin A stands out as a precise tool for dissecting actin cytoskeleton dynamics, enabling rapid and reversible disruption ideal for studies of cell morphology, motility, and disease models. Its predictable action, as highlighted in new axon regeneration research, translates into reproducible workflows and advanced troubleshooting for cytoskeleton-dependent assays.

• Neutrophil Extracellular Traps in CML: Impact of Kinase Inhi

  2026-07-24

  This study reveals that neutrophil extracellular trap (NET) formation is elevated in chronic myeloid leukemia (CML) and is differentially modulated by various tyrosine kinase inhibitors (TKIs). The findings highlight a possible mechanistic link between TKI therapy, NETs, and vascular complications, with implications for the design of safer therapeutic strategies.

• Necrosulfonamide: Advancing Translational Necroptosis Resear

  2026-07-23

  Explore how Necrosulfonamide (NSA) is reshaping the study of necroptosis by bridging mechanistic insights on MLKL inhibition with strategic guidance for translational researchers. This article contextualizes NSA's experimental value in cell death pathway research, highlights best-practice protocols, and draws on recent findings in cardiovascular and neurodegenerative models to inform future directions.

• Bufuralol Hydrochloride: Precision β-Adrenergic Antagonism i

  2026-07-23

  Explore how Bufuralol hydrochloride enables advanced β-adrenergic modulation in cutting-edge cardiovascular pharmacology research. This article uniquely bridges non-selective β-adrenergic receptor antagonism with hiPSC-derived intestinal organoid pharmacokinetic modeling.

• MK-5108 (VX-689) Aurora-A Inhibitor: Advanced Cancer Assays

  2026-07-22

  MK-5108 (VX-689) delivers nanomolar potency and selectivity for Aurora A kinase, empowering precise cell cycle inhibition studies in diverse cancer models. Its application in retinoblastoma and other high-risk tumor research enables robust, reproducible workflows and the exploration of targeted therapy strategies that address chemotherapy resistance.

• Rocilinostat (ACY-1215): Optimizing HDAC6 Inhibition Workflo

  2026-07-22

  Rocilinostat (ACY-1215) empowers researchers to dissect HDAC6’s role in cancer and neurodevelopmental disorders with unmatched selectivity and workflow flexibility. Explore protocol enhancements, troubleshooting strategies, and cross-domain insights that drive robust, reproducible results in multiple myeloma and beyond.

• PKH26 Red Fluorescent Cell Linker Kit: Protocol and Workflow

  2026-07-21

  The PKH26 Red Fluorescent Cell Linker Kit provides a robust solution for stable, membrane-specific labeling required for cell tracing and proliferation detection in vitro and in vivo. It is unsuitable for intracellular or non-membrane applications, making protocol adherence critical for reliable results.

• OTC Inhibition, Ornithine Accumulation, and Astrocyte Energy

  2026-07-21

  This study elucidates how realgar-derived arsenic impairs the liver–brain axis by inhibiting hepatic ornithine transcarbamylase (OTC), leading to ornithine accumulation and ZBTB7A-mediated repression of astrocyte glycolysis. The findings reveal a new mechanistic link between disrupted urea cycle function and central nervous system energy deficits, providing novel targets for neurotoxicity intervention.

• Dimetridazole Potentiates Cefotaxime Against MDR E. coli via

  2026-07-20

  This study reveals that dimetridazole, a 1,2-dimethyl-5-nitroimidazole compound, significantly enhances the antibacterial activity of cefotaxime against multidrug-resistant Escherichia coli by targeting bacterial membrane integrity and fatty acid biosynthesis. The findings highlight a promising combination strategy for overcoming antibiotic resistance, with implications for both mechanistic research and translational antimicrobial applications.

453 records 10/31 page Previous Next First page 上5页 678910 下5页 Last page